Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) is one of the largest pharmaceutical groups in China, engaged in the research and development, manufacturing, distribution, and retail of pharmaceutical products. They operate a comprehensive value chain across the pharmaceutical industry.
Serves as the central hub for corporate management, strategic decision-making, and overall business operations.
Likely houses key departments such as R&D, finance, and executive leadership, though publicly available details on specific internal features are limited.
Reflects a corporate environment with a focus on innovation, research, and adherence to regulatory standards, typical of large pharmaceutical companies.
Functions as the strategic and operational command center of one of China's leading pharmaceutical companies, crucial for its nationwide and international endeavors.
Shanghai Pharmaceuticals' global presence includes international partnerships for research and development, sourcing raw materials, and distributing pharmaceutical products in select markets. They primarily focus on expansion within Asia and strategic partnerships globally.
No. 82 Fenyang Road
Shanghai
N/A
China
Address: Varies depending on the specific subsidiary or branch
Facilitates regional sales, marketing, and distribution of pharmaceutical products, supporting SPH's market penetration in different regions of China.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Shanghai Pharmaceuticals Holding Co., Ltd.' leadership includes:
Shanghai Pharmaceuticals Holding Co., Ltd. has been backed by several prominent investors over the years, including:
Information about executive new hires/exits in the last 12 months is not easily found.
Discover the tools Shanghai Pharmaceuticals Holding Co., Ltd. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email formats at Shanghai Pharmaceuticals are likely variations of first name, last name, and initials. Due to limited available information, examples and success rates are estimated.
[first].[last]@sphchina.com
Format
john.doe@sphchina.com
Example
50%
Success rate
Reuters • 2024-07-10
Sanofi SA is in advanced talks to sell its consumer health business in China to Shanghai Pharmaceuticals Holding Co. Ltd. in a deal potentially worth about $1 billion, Bloomberg News reported on Tuesday, citing people familiar with the matter....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Shanghai Pharmaceuticals Holding Co., Ltd., are just a search away.